Drug Shortage Report for EPINEPHRINE INJECTION USP

Last updated on 2022-06-15 History
Report ID 153789
Drug Identification Number 00710814
Brand name EPINEPHRINE INJECTION USP
Common or Proper name EPINEPHRINE INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) EPINEPHRINE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRACARDIAC INTRAVENOUS INTRACARDIAC
Packaging size 10 x 10mL LifeShield syringes
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-01-28
Estimated end date 2022-08-01
Actual end date
Shortage status Actual shortage
Updated date 2022-06-15
Company comments Inventory remains on strict preventative allocation. Epinephrine ampoules remain fully available.
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-06-15 French Compare
v6 2022-06-15 English Compare
v5 2022-03-15 French Compare
v4 2022-03-15 English Compare
v3 2022-01-29 English Compare
v2 2022-01-28 French Compare
v1 2022-01-28 English Compare

Showing 1 to 7 of 7